Join the 200th Anniversary Celebration

Original Article

Relation of Alleles of the Collagen Type Iα1 Gene to Bone Density and the Risk of Osteoporotic Fractures in Postmenopausal Women

André G. Uitterlinden, Ph.D., Huibert Burger, M.D., Ph.D., Qiuju Huang, M.D., Fang Yue, M.D., Fiona E.A. McGuigan, B.Sc., Struan F.A. Grant, Ph.D., Albert Hofman, M.D., Ph.D., Johannes P.T.M. van Leeuwen, Ph.D., Huibert A.P. Pols, M.D., Ph.D., and Stuart H. Ralston, M.D.

N Engl J Med 1998; 338:1016-1021April 9, 1998

Abstract

Background

Osteoporosis is a common disorder with a strong genetic component. One way in which the genetic component could be expressed is through polymorphism of COLIA1, the gene for collagen type Iα1, a bone-matrix protein.

Methods

We determined the COLIA1 genotypes SS, Ss, and ss in a population-based sample of 1778 postmenopausal women using a polymerase-chain-reaction–based assay. We then related the genotypes to bone mineral density and the occurrence of osteoporotic fractures in these women.

Results

As compared with the 1194 women with the SS genotype, the 526 women with the Ss genotype had 2 percent lower bone mineral density at the femoral neck (P = 0.003) and the lumbar spine (P = 0.02); the 58 women with the ss genotype had reductions of 4 percent at the femoral neck (P = 0.05) and 6 percent at the lumbar spine (P = 0.005). These differences increased with age (P = 0.01 for modification by age of the effect of COLIA1 on femoral-neck bone density, and P = 0.004 for modification of the effect on lumbar-spine bone density). Women with the Ss and ss genotypes were overrepresented among the 111 women who had incident nonvertebral fractures (relative risk per copy of the s allele, 1.5; 95 percent confidence interval, 1.1 to 2.1).

Conclusions

The COLIA1 polymorphism is associated with reduced bone density and predisposes women to osteoporotic fractures.

Media in This Article

Figure 1Mean (±SE) Age-Related Differences in Bone Mineral Density of the Femoral Neck (Panel A) and Lumbar Spine (Panel B) in Postmenopausal Women According to COLIA1 Genotype.
Table 1Characteristics of 1778 Postmenopausal Women According to Their COLIA1 Genotype.
Article

Osteoporosis is a common disorder characterized by reduced bone mineral density, deterioration of the microarchitecture of bone tissue, and increased risk of fracture.1 Evidence from twin and family studies suggests that genetic factors have a major role in the pathogenesis of osteoporosis,2-6 and segregation analysis has shown that bone mineral density is under polygenic control.7 Pedigree studies of monogenetic disorders have been conducted to identify genes that could subsequently be analyzed for their contribution to the pathogenesis of osteoporosis on a population-wide basis. For example, loss-of-function mutations in the gene for the vitamin D receptor are responsible for the bone disease that characterizes 1α,25-dihydroxyvitamin D–resistant rickets.8,9 Some, but not all, subsequent population-based and twin studies found that polymorphisms of the vitamin D receptor were associated with differences in bone density.10,11 A man with a loss-of-function mutation of the estrogen-receptor gene had osteoporosis,12 but intronic polymorphisms of this gene have not been consistently associated with differences in bone density in population-based studies of women.13,14

Similarly, girls with loss-of-function mutations in the aromatase P450 gene, who cannot synthesize estrogen, have osteoporosis,15 but no population-based studies of this gene have been published. In more recent pedigree studies, a locus for “high peak bone density” and the locus for the osteoporosis–pseudoglioma syndrome, a recessive disorder characterized by juvenile-onset blindness and osteoporosis, were mapped to the same region on chromosome 11,16,17 suggesting the presence of a gene with effects on bone density. Polymorphisms of other candidate genes, such as the genes for interleukin-6 and transforming growth factor β, have also been associated with differences in bone density in some populations.18,19

The genes encoding collagen types Iα1 and Iα2 (COLIA1 and COLIA2, respectively) are also important candidates for the genetic regulation of bone density, because mutations that affect the coding regions of these genes cause osteogenesis imperfecta.20 Although the coding regions of collagen genes are normal in the vast majority of patients with osteoporosis,21 we described a novel guanine-to-thymidine polymorphism at the first base of a binding site for the transcription factor Sp1 in the first intron of the COLIA1 gene that was associated with low bone density and increased occurrence of osteoporotic vertebral fracture in 299 British women.22 To determine whether this polymorphism predicts bone density and the risk of osteoporotic fracture in other populations, we studied the relation of the COLIA1 polymorphism to bone density and osteoporotic fracture in 1778 postmenopausal women in the Netherlands.23

Methods

Study Subjects

The Rotterdam Study is a population-based cohort study of 7983 subjects who are at least 55 years old and who live in the Ommoord district of Rotterdam, the Netherlands. The study was designed to document the occurrence of disease in the elderly in relation to several potential determinants.23 A total of 10,275 persons, of whom 9161 (89 percent) were living independently, were invited to participate in the study in 1991. Among the subjects living independently, the overall response rate was 77 percent for the home interview and 71 percent for the examination in a research center, where anthropometric characteristics and bone mineral density were measured and blood samples were taken. The Rotterdam Study was approved by the medical ethics committee of the Erasmus University Medical School, and written informed consent was obtained from each subject.

The association between the COLIA1 genotype and osteoporosis was analyzed in a subgroup of women participating in the study. Base-line measurements of bone mineral density were available for 5931 subjects who were living independently. Of these, 1453 were excluded because they were more than 80 years of age, used a walking aid, had diabetes mellitus, or were taking diuretics, estrogen, thyroid hormone, or cytostatic drugs. From the 4478 remaining subjects, we studied a random sample of 2000 women who were 55 to 80 years old. Bone-density data or DNA samples were not available for 222 women, resulting in a final study group of 1778 women.

Measurements

Height and weight were measured at the initial examination, with the subject in a standing position without shoes. Bone mineral density (in grams per square centimeter) was determined by dual-energy x-ray absorptiometry (DPX-L densitometer, Lunar, Madison, Wis.) at the femoral neck and lumbar spine (vertebrae L2, L3, and L4), as described elsewhere.24 Dietary intake of calcium (in milligrams per day) during the preceding year was assessed by a food-frequency questionnaire and adjusted for energy intake. Age at menopause and current use of cigarettes and alcohol were assessed by questionnaire. For 1423 women (80 percent), lateral radiographs of the spine from the fourth thoracic to the fifth lumbar vertebra were obtained at base line and examined for the presence of prevalent vertebral fractures by morphometric analysis, as previously described.25 Incident nonvertebral fractures, including hip, wrist, and other fractures, were recorded, confirmed, and classified by a physician over a mean follow-up period of 3.8 years.

Determination of COLIA1 Genotypes

Genomic DNA was extracted from samples of peripheral venous blood according to standard procedures, and the intronic polymorphism of the COLIA1 gene was detected by the polymerase chain reaction (PCR) with a mismatched primer that introduces a diallelic restriction site, as previously described.22 The test discriminates two alleles, S and s, which correspond to the presence of guanine and thymidine, respectively, as the first bases in the Sp1-binding site in the first intron of the gene for COLIA1. The reaction mixture of 25 μl contained 100 ng of genomic DNA, 50 mM potassium chloride, 10 mM TRIS–hydrochloric acid (pH 8.3), 1.5 mM magnesium chloride, 0.2 mM dideoxynucleotide triphosphates, 150 ng of each primer, and 0.2 unit of Super Taq polymerase (HT Biotechnology, Cambridge, United Kingdom). The reactions were performed in a DNA thermocycler (mode 480, Perkin–Elmer, Foster City, Calif.) with a cycling protocol of 94°C, 60°C, and 72°C for one minute each, for 35 cycles. Ten microliters of PCR product was digested with 2 units of MscI restriction enzyme and 1.2 μl of a buffer, containing 150 mM TRIS–hydrochloric acid (pH 7.5), 250 mM sodium chloride, and 35 mM magnesium chloride, by incubation for 30 minutes at 37°C. The digestion products underwent electrophoresis on a 3 percent NuSieve agarose gel (FMC BioProducts, Rockland, Me.) in 44.5 mM TRIS, 44.5 mM boric acid, and 1 mM disodium EDTA for 300 volt-hours. The separation patterns were documented by Polaroid photography under ultraviolet illumination (302 nm). To confirm the accuracy of the genotyping, repeated analysis was performed on 400 randomly selected samples, including those from all ss homozygotes. No discrepancies were found.

Statistical Analysis

Bone mineral density and other relevant clinical variables of the three genotype groups were compared by analysis of covariance. Multiple linear regression was used to adjust bone-density values for confounding factors such as age, anthropometric variables, calcium intake, smoking, and alcohol use. A multivariate linear regression model was designed to test for the changing effects of COLIA1 genotype on bone density with age. For this analysis, the subjects were classified into five-year age groups (55 to 59, 60 to 64, 65 to 69, 70 to 74, and 75 to 80 years), and the COLIA1 genotypes were assigned values of 0, 1, or 2, according to the number of s alleles present. The analysis included an interaction term defined as age group multiplied by gene dose (the number of s alleles). The variance of bone density that could be explained by the COLIA1 genotype was calculated by linear regression analysis adjusted for weight and age. The chi-square test was used to test for Hardy–Weinberg equilibrium, the distribution of alleles in women of different age groups, and the distribution of alleles in women with and without fractures. Odds ratios (with 95 percent confidence intervals) were calculated by multivariate logistic-regression analysis to estimate the relative risk of osteoporotic fracture. All statistical tests were two-sided.

Results

Characteristics of the Study Subjects

Table 1Table 1Characteristics of 1778 Postmenopausal Women According to Their COLIA1 Genotype. shows anthropometric, dietary, and bone-density measurements according to COLIA1 genotype. The allelic frequencies (82 percent for the S allele and 18 percent for the s allele) and the distribution of genotypes were similar to those reported in a previous study22 and were as predicted by the Hardy–Weinberg equation, confirming that no genotype was being selectively sampled (P = 1.00). The three genotype groups did not differ significantly in age, age at menopause, dietary calcium intake, smoking habits, alcohol intake, or height. There was a significant gene-dose effect on body weight (-0.97 kg per copy of the s allele, P = 0.03): body weight was lower in the Ss group than in the SS group, and lowest in the ss group.

Association between Genotype and Bone Mineral Density

The three genotype groups differed significantly in bone mineral density at the femoral neck and the lumbar spine. At both sites, bone mineral density was highest in the SS group and lowest in the ss group (Table 1). Bone mineral density in the Ss group was 2 percent less than that in the SS group at both sites (P =0.003 for femoral neck and P = 0.02 for lumbar spine). In the ss group, bone mineral density in the femoral neck was 4 percent less than that in the SS group (P = 0.05), and in the lumbar spine it was 6 percent less than that in the SS group (P = 0.005). Table 2Table 2COLIA1 Gene-Dose Effect on Bone Density of Postmenopausal Women According to Age. shows that these differences corresponded to significant gene-dose effects at the femoral neck and lumbar spine (P<0.001 for both sites). The effects of COLIA1 genotype on bone density of the Ward's triangle and trochanter sites at the hip were similar (data not shown). The percentage of the variance in bone density explained by the COLIA1 genotype was 0.3 percent at the femoral neck and 0.4 percent at the lumbar spine. When the bone-density values were adjusted for confounding variables resulting from the association between genotype and body weight, the differences between genotype groups were smaller, but they were still statistically significant.

Bone density declines with age, and genetic effects on bone density could theoretically be mediated by differences in the age-related rate of bone loss,26 as well as by differences in peak bone density. We therefore assessed the effect of age on the relation between COLIA1 genotype and bone density. When the study subjects were divided into five-year age categories, the differences in bone density between the genotype groups were small among the younger women (55 to 65 years old) but became larger with increasing age (Figure 1AFigure 1Mean (±SE) Age-Related Differences in Bone Mineral Density of the Femoral Neck (Panel A) and Lumbar Spine (Panel B) in Postmenopausal Women According to COLIA1 Genotype. and Figure 1B). Among women 75 to 80 years of age, bone mineral density in the Ss group was 5 percent lower at the femoral neck (P = 0.03) and 3 percent lower at the lumbar spine (P = 0.26) than that in the SS group. In the ss group, bone mineral density was 12 percent lower at the femoral neck (P = 0.04) and 20 percent lower at the lumbar spine (P = 0.004) than that in the SS group. These numbers indicate an increased gene-dose effect with increasing age at both the femoral neck and the lumbar spine (Table 2).

When age, genotype, and bone density were considered together in a multivariate regression model, we found that age significantly modified the effect of the COLIA1 genotype on bone density, at both the femoral neck (P = 0.01 for the interaction term) and the lumbar spine (P= 0.004 for the interaction term). The percentage of the variance in bone density accounted for by the COLIA1 genotype became larger with age, reaching 2 percent for women 75 to 80 years of age. These differences were not explained by differences in the distribution of genotypes, because the allelic frequencies did not change with increasing age and the distribution of genotypes in each age group was similar to that in the study group as a whole.

Association between Genotype and Fractures

Table 3Table 3Number of Postmenopausal Women with Fractures and Odds Ratios for Fractures According to COLIA1 Genotype. shows the distribution of incident nonvertebral fractures and prevalent vertebral compression fractures according to COLIA1 genotype. Significantly more women with the Ss genotype had incident nonvertebral fractures or prevalent vertebral fractures than women with the SS genotype. Among women with the ss genotype, this difference increased for incident nonvertebral fractures (P = 0.02) but not for prevalent vertebral fractures (P = 0.33).

Logistic-regression analysis showed that for incident nonvertebral fractures, the women in the Ss group had 1.4 times the risk of the women in the SS group, and the women in the ss group had 2.8 times the risk of the women in the SS group. The overall gene-dose effect was an odds ratio of 1.5 per copy of the s allele: 3.1 for the hip (95 percent confidence interval, 1.2 to 7.6; 10 cases), 1.4 for the wrist (95 percent confidence interval, 0.8 to 2.5; 36 cases), and 1.4 for other fractures (95 percent confidence interval, 0.9 to 2.1; 65 cases). The risk of vertebral fracture was slightly increased in women in the Ss group but not in those in the ss group. The relative risk of fracture did not change after adjustment for potential confounding factors such as age, weight, and bone density in the regression analysis (Table 3).

Discussion

Genetic factors have an important role in determining bone density,2-6,27 and bone density is an important determinant of the risk of osteoporotic fracture.28,29 The genes for collagen types Iα1 and Iα2 (COLIA1 and COLIA2) are important candidates for regulators of bone density and risk of fracture, because point mutations that affect their coding regions result in osteogenesis imperfecta.20 Although similar mutations in the coding regions of the collagen genes have not been found in patients with osteoporosis,21 the polymorphism that we described, which affects a binding site for the transcription factor Sp1 in a regulatory region of the COLIA1 gene, was associated with differences in bone density and risk of fracture in 299 British women.22 The data presented here confirm and extend these findings to a population-based cohort of 1778 postmenopausal women from the Netherlands. We found a consistent association between this COLIA1 polymorphism and differences in bone density at the spine and hip, with evidence of gene-dose effects at both sites: bone-density values were highest in women with the SS genotype, intermediate in those with the Ss genotype, and lowest in those with the rare ss genotype.

These differences in bone density were accompanied by differences in body weight, and the difference between genotypes in bone density was reduced in magnitude after correction for weight. This is not unexpected in view of the close association between weight and bone density30,31 and suggests that the association between COLIA1 genotype and bone density may be mediated in part by a genetic effect of COLIA1 on body weight.

The genotype-specific differences in bone density were small in the study group as a whole but increased with age. The allelic frequencies did not change with age, an observation that argues against selection bias due to mortality-related effects of the polymorphism as an explanation for this effect. This raises the possibility that the COLIA1 polymorphism may be a marker for accelerated bone loss in older women, rather than a marker for lower peak bone density.

The overrepresentation of the Ss and ss genotypes among women with osteoporotic fractures was not unexpected, in view of the well-established relation between bone density and risk of fracture,28,29 which was also found in this study. The relative risk of fracture, however, was about two to three times as great as that predicted by the differences between genotypes in bone density, and it remained significant after adjustment for weight and bone density. This raises the possibility that the COLIA1 polymorphism may act as a marker for differences in bone quality, such as bone structure or matrix composition, as well as bone quantity. The number of fractures was small, however.

The mechanisms by which the different COLIA1 alleles affect bone density and fracture risk are not known. Oligonucleotides corresponding to the s allele bind the Sp1 protein with greater affinity than those corresponding to the S allele,32 and subjects who are heterozygous for the polymorphism have three times as many transcripts derived from the s allele as from the S allele (unpublished data). This raises the possibility that carriage of the s allele may be associated with a disturbance in the relative abundance of COLIA1 and COLIA2 messenger RNAs, as occurs in osteogenesis imperfecta.33

Studies of the genetic basis of osteoporosis are important to identify genes that act as regulators of bone density, bone quality, and the risk of fracture. Genetic markers for osteoporosis could be useful clinically for identifying subjects at risk of osteoporosis and for targeting preventive treatment. The association we describe between COLIA1 genotype and osteoporotic fracture in postmenopausal women, coupled with the divergence of bone-density values with increasing age between different genotype groups, raises the possibility that genotyping at the polymorphic COLIA1 Sp1 site may provide information on susceptibility to osteoporotic fracture that could complement information gained from bone-density measurements alone.

Supported by grants from the Dutch Praeventiefonds (002824890), the Nestor stimulation program for geriatric research in the Netherlands (Ministry of Health and Ministry of Education), the Municipality of Rotterdam, the Netherlands Organization for Scientific Research, the European Commission, the Chief Scientist's Office of the Scottish Home and Health Department, the Wellcome Trust, and the Grampian Osteoporosis Trust.

Source Information

From the Departments of Internal Medicine III (A.G.U., J.P. T.M.L., H.A.P.P.) and Epidemiology and Biostatistics (A.G.U., H.B., Q.H., F.Y., A.H., H.A.P.P.), Erasmus University Medical School, Rotterdam, the Netherlands; and the Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom (F.E.A.M., S.F.A.G., S.H.R.).

Address reprint requests to Dr. Uitterlinden at the Department of Internal Medicine III, FGG-EUR, Erasmus University Medical School, P.O. Box 1738, 3000 DR Rotterdam, the Netherlands.

References

References

  1. 1

    Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-1141
    CrossRef | Web of Science | Medline

  2. 2

    Smith DM, Nance WE, Kang KW, Christian JC, Johnston CC Jr. Genetic factors in determining bone mass. J Clin Invest 1973;52:2800-2808
    CrossRef | Web of Science | Medline

  3. 3

    Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S. Genetic determinants of bone mass in adults: a twin study. J Clin Invest 1987;80:706-710
    CrossRef | Web of Science | Medline

  4. 4

    Evans RA, Marel GM, Lancaster EK, Kos S, Evans M, Wong SYP. Bone mass is low in relatives of osteoporotic patients. Ann Intern Med 1988;109:870-873
    Web of Science | Medline

  5. 5

    Seeman E, Hopper JL, Bach LA, et al. Reduced bone mass in daughters of women with osteoporosis. N Engl J Med 1989;320:554-558
    Full Text | Web of Science | Medline

  6. 6

    Soroko SB, Barrett-Connor E, Edelstein SL, Kritz-Silverstein D. Family history of osteoporosis and bone mineral density at the axial skeleton: the Rancho Bernardo Study. J Bone Miner Res 1994;9:761-769
    CrossRef | Web of Science | Medline

  7. 7

    Gueguen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Siest G. Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res 1995;12:2017-2022
    CrossRef

  8. 8

    Hughes MR, Malloy PJ, Kieback DG, et al. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science 1988;242:1702-1705
    CrossRef | Web of Science | Medline

  9. 9

    Malloy PJ, Weisman Y, Feldman D. Hereditary 1α,25-dihydroxyvitamin D-resistant rickets resulting from a mutation in the vitamin D receptor deoxyribonucleic acid-binding domain. J Clin Endocrinol Metab 1994;78:313-316
    CrossRef | Web of Science | Medline

  10. 10

    Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994;367:284-287
    CrossRef | Web of Science | Medline

  11. 11

    Cooper GS, Umbach DM. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res 1996;11:1841-1849
    CrossRef | Web of Science | Medline

  12. 12

    Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994;331:1056-1061
    Full Text | Web of Science | Medline

  13. 13

    Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H. Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 1996;11:306-311
    CrossRef | Web of Science | Medline

  14. 14

    Han KO, Moon IG, Kang YS, Chung HY, Min HK, Han IK. Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women. J Clin Endocrinol Metab 1997;82:991-995
    CrossRef | Web of Science | Medline

  15. 15

    Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995;80:3689-3698
    CrossRef | Web of Science | Medline

  16. 16

    Gong Y, Vikkula M, Boon L, et al. Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am J Hum Genet 1996;59:146-151
    Web of Science | Medline

  17. 17

    Johnson ML, Gong G, Kimberling W, Recker SM, Kimmel DB, Recker RB. Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13). Am J Hum Genet 1997;60:1326-1332
    CrossRef | Web of Science | Medline

  18. 18

    Murray RE, McGuigan F, Grant SFA, Reid DM, Ralston SH. Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone 1997;21:89-92
    CrossRef | Web of Science | Medline

  19. 19

    Langdahl BL, Knudsen JY, Jensen HK, Gregersen N, Eriksen EF. A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 1997;3:289-294
    CrossRef | Web of Science

  20. 20

    Byers PH, Steiner RD. Osteogenesis imperfecta. Annu Rev Med 1992;43:269-282
    CrossRef | Web of Science | Medline

  21. 21

    Spotila LD, Colige A, Sereda L, et al. Mutation analysis of coding sequences for type I procollagen in individuals with low bone density. J Bone Miner Res 1994;9:923-932
    CrossRef | Web of Science | Medline

  22. 22

    Grant SFA, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α1 gene. Nat Genet 1996;14:203-205
    CrossRef | Web of Science | Medline

  23. 23

    Hofman A, Grobbee DE, de Jong PTVM, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991;7:403-422
    CrossRef | Web of Science | Medline

  24. 24

    Burger H, van Daele PLA, Algra D, et al. The association between age and bone mineral density in men and women aged 55 years and over: the Rotterdam Study. Bone Miner 1994;25:1-13
    CrossRef | Medline

  25. 25

    Burger H, Van Daele PLA, Grashuis K, et al. Vertebral deformities and functional impairment in men and women. J Bone Miner Res 1997;12:152-157
    CrossRef | Web of Science | Medline

  26. 26

    Kelly PJ, Nguyen T, Hopper J, Pocock N, Sambrook P, Eisman J. Changes in axial bone density with age: a twin study. J Bone Miner Res 1993;8:11-17
    CrossRef | Web of Science | Medline

  27. 27

    Jouanny P, Guillemin F, Kuntz C, Jeandel C, Pourel J. Environmental and genetic factors affecting bone mass: similarity of bone density among members of healthy families. Arthritis Rheum 1995;38:61-67
    CrossRef | Web of Science | Medline

  28. 28

    Hui SL, Slemenda CW, Johnston CC Jr. Baseline measurement of bone mass predicts fracture in white women. Ann Intern Med 1989;111:355-361
    Web of Science | Medline

  29. 29

    Cummings SR, Black DM, Nevitt MC, et al. Bone density at various sites for prediction of hip fractures. Lancet 1993;341:72-75
    CrossRef | Web of Science | Medline

  30. 30

    Krall EA, Dawson-Hughes B. Heritable and life-style determinants of bone mineral density. J Bone Miner Res 1993;8:1-9
    CrossRef | Web of Science | Medline

  31. 31

    Seeman E, Hopper JL, Young NR, Formica C, Goss P, Tsalamandris C. Do genetic factors explain associations between muscle strength, lean mass, and bone density? A twin study. Am J Physiol 1996;270:E320-E327
    Web of Science | Medline

  32. 32

    Grant SFA. Studies on the genetic susceptibility to osteoporosis: analysis of cis-acting sequences in the collagen I α 1 gene. (Ph.D. thesis. Aberdeen, Scotland: University of Aberdeen, 1996.)

  33. 33

    Willing MC, Deschenes SP, Scott DA, et al. Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen. Am J Hum Genet 1994;55:638-647
    Web of Science | Medline

Citing Articles (170)

Citing Articles

  1. 1

    David Rojano-Mejía, Ramón M. Coral-Vázquez, Leticia Cortes Espinosa, Guillermo López-Medina, María C. Aguirre-García, Agustín Coronel, Patricia Canto. (2011) JAG1 and COL1A1 polymorphisms and haplotypes in relation to bone mineral density variations in postmenopausal Mexican-Mestizo Women. AGE
    CrossRef

  2. 2

    Monica Singh, Puneetpal Singh, Surinder Singh, Pawan Kumar Juneja, Taranpal Kaur. (2011) A haplotype derived from the common variants at the −1997G/T and Sp1 binding site of the COL1A1 gene influences risk of postmenopausal osteoporosis in India. Rheumatology International
    CrossRef

  3. 3

    Patrick Yu-Ping Kao, Danny Chan, Dino Samartzis, Pak Chung Sham, You-Qiang Song. (2011) Genetics of Lumbar Disk Degeneration: Technology, Study Designs, and Risk Factors. Orthopedic Clinics of North America 42:4, 479-486
    CrossRef

  4. 4

    Edith Falcón-Ramírez, Leonora Casas-Avila, Antonio Miranda, Pilar Diez, Clementina Castro, Julieta Rubio, Rocío Gómez, Margarita Valdés-Flores. (2011) Sp1 polymorphism in collagen I α1 gene is associated with osteoporosis in lumbar spine of Mexican women. Molecular Biology Reports 38:5, 2987-2992
    CrossRef

  5. 5

    N. González-Bofill, L. B. Husted, T. Harsløf, C. L. Tofteng, B. Abrahamsen, P. Eiken, P. Vestergaard, B. L. Langdahl. (2011) Effects of COLIA1 polymorphisms and haplotypes on perimenopausal bone mass, postmenopausal bone loss and fracture risk. Osteoporosis International 22:4, 1145-1156
    CrossRef

  6. 6

    M. O. Erdogan, H. Yıldız, S. Artan, M. Solak, F. Taşcıoğlu, Ü. Dündar, B. Eser, E. Çolak. (2011) Association of estrogen receptor alpha and collagen type I alpha 1 gene polymorphisms with bone mineral density in postmenopausal women. Osteoporosis International 22:4, 1219-1225
    CrossRef

  7. 7

    H. Jin, E. Evangelou, J. P. A. Ioannidis, S. H. Ralston. (2011) Polymorphisms in the 5′ flank of COL1A1 gene and osteoporosis: meta-analysis of published studies. Osteoporosis International 22:3, 911-921
    CrossRef

  8. 8

    Hanan M Hamed, Ashraf Galal, Mona EL Ghamrawy, Khaled Abd El Azeem, Ibtessam Ramzi Hussein, Mona Fayez Abd-Elgawad. (2011) An SP1-binding site polymorphism in the COLIAI gene and osteoporosis in Egyptian patients with thalassemia major. Blood Coagulation & Fibrinolysis 22:2, 81-85
    CrossRef

  9. 9

    Tilman E. Klassert, Juan J. Sánchez, Teresa A. Almeida, Luz Candenas, Francisco Pinto, Orlando Acosta, Mariano Hernández. (2010) Common variants of the neuropeptide expressing tachykinin genes and susceptibility to asthma: A case–control study. Journal of Neuroimmunology 227:1-2, 202-207
    CrossRef

  10. 10

    Kuen Tak Suh, Il-Soo Eun, Jung Sub Lee. (2010) Polymorphism in vitamin D receptor is associated with bone mineral density in patients with adolescent idiopathic scoliosis. European Spine Journal 19:9, 1545-1550
    CrossRef

  11. 11

    Tomohiko Urano, Masataka Shiraki, Takahiko Usui, Noriko Sasaki, Yasuyoshi Ouchi, Satoshi Inoue. (2010) Identification of non-synonymous polymorphisms in the WDSOF1 gene as novel susceptibility markers for low bone mineral density in Japanese postmenopausal women. Bone 47:3, 636-642
    CrossRef

  12. 12

    Z.-M. Zhang, Z.-C. Li, L.-S. Jiang, S.-D. Jiang, L.-Y. Dai. (2010) Micro-CT and mechanical evaluation of subchondral trabecular bone structure between postmenopausal women with osteoarthritis and osteoporosis. Osteoporosis International 21:8, 1383-1390
    CrossRef

  13. 13

    Katarina Trajkovic, Milka Perovic, Aleksej Tarasjev, Nada Pilipovic, Vera Popovic, Selma Kanazir. (2010) Association of Collagen Type I α1 Gene Polymorphism with Bone Mineral Density in Osteoporotic Women in Serbia. Journal of Women's Health 19:7, 1299-1303
    CrossRef

  14. 14

    Qi Zhao, James E Hixson, Dabeeru C Rao, Dongfeng Gu, Cashell E Jaquish, Treva Rice, Lawrence C Shimmin, Jichun Chen, Jie Cao, Tanika N Kelly, Lotuce Lee Hamm, Jiang He. (2010) Genetic variants in the apelin system and blood pressure responses to dietary sodium interventions: a family-based association study. Journal of Hypertension 28:4, 756-763
    CrossRef

  15. 15

    P. F. Giampietro, C. McCarty, B. Mukesh, F. McKiernan, D. Wilson, A. Shuldiner, J. Liu, J. LeVasseur, L. Ivacic, T. Kitchner, N. Ghebranious. (2010) The role of cigarette smoking and statins in the development of postmenopausal osteoporosis: a pilot study utilizing the Marshfield Clinic Personalized Medicine Cohort. Osteoporosis International 21:3, 467-477
    CrossRef

  16. 16

    George Feldman, Chelsea Dalsey, Kasia Fertala, David Azimi, Paolo Fortina, Marcella Devoto, Maurizio Pacifici, Javad Parvizi. (2010) The Otto Aufranc Award: Identification of a 4 Mb Region on Chromosome 17q21 Linked to Developmental Dysplasia of the Hip in One 18-member, Multigeneration Family. Clinical Orthopaedics and Related Research® 468:2, 337-344
    CrossRef

  17. 17

    Francesca Marini, Maria Luisa Brandi. (2010) Genetic Determinants of Osteoporosis: Common Bases to Cardiovascular Diseases?. International Journal of Hypertension 2010, 1-16
    CrossRef

  18. 18

    Hyung Jin Choi, Ji Yeob Choi, Sun Wook Cho, Daehee Kang, Ki Ok Han, Sang Wan Kim, Seong Yeon Kim, Yoon-Sok Chung, Chan Soo Shin. (2010) Genetic Polymorphism of Geranylgeranyl Diphosphate Synthase (GGSP1) Predicts Bone Density Response to Bisphosphonate Therapy in Korean Women. Yonsei Medical Journal 51:2, 231
    CrossRef

  19. 19

    Bich N. H. Tran, Nguyen D. Nguyen, Jacqueline R. Center, John A. Eisman, Tuan V. Nguyen. (2009) Enhancement of Absolute Fracture Risk Prognosis with Genetic Marker: The Collagen I Alpha 1 Gene. Calcified Tissue International 85:5, 379-388
    CrossRef

  20. 20

    Tomohiko Urano, Masataka Shiraki, Takahiko Usui, Noriko Sasaki, Yasuyoshi Ouchi, Satoshi Inoue. (2009) Bone mass effects of a Smad6 gene polymorphism in Japanese postmenopausal women. Journal of Bone and Mineral Metabolism 27:5, 562-566
    CrossRef

  21. 21

    Keizo Ohnaka, Ken Yamamoto, Kenjiro Nakamura, Masahiro Adachi, Hisaya Kawate, Suminori Kono, Ryoichi Takayanagi. (2009) Association of single nucleotide polymorphisms in secreted frizzled-related protein 1 gene with bone mineral density in Japanese women. Geriatrics & Gerontology International 9:3, 304-309
    CrossRef

  22. 22

    Irmgard Tegeder, Jörn Lötsch. (2009) Current evidence for a modulation of low back pain by human genetic variants. Journal of Cellular and Molecular Medicine 13:8b, 1605-1619
    CrossRef

  23. 23

    Ji Young Lee, Woon Jeong Lee, Sung Eun Hur, Chul Min Lee, Yeon-Ah Sung, Hye Won Chung. (2009) 111/121 diplotype of Calpain-10 is associated with the risk of polycystic ovary syndrome in Korean women. Fertility and Sterility 92:2, 830-833
    CrossRef

  24. 24

    Yue Fang, Joyce B. J. Meurs, Pascal Arp, Johannes P. T. Leeuwen, Albert Hofman, Huibert A. P. Pols, André G. Uitterlinden. (2009) Vitamin D Binding Protein Genotype and Osteoporosis. Calcified Tissue International 85:2, 85-93
    CrossRef

  25. 25

    H. Jin, R. J. van't Hof, O. M.E. Albagha, S. H. Ralston. (2009) Promoter and intron 1 polymorphisms of COL1A1 interact to regulate transcription and susceptibility to osteoporosis. Human Molecular Genetics 18:15, 2729-2738
    CrossRef

  26. 26

    Katarina Lindahl, Carl-Johan Rubin, Helena Brändström, Magnus K. Karlsson, Anna Holmberg, Claes Ohlsson, Dan Mellström, Eric Orwoll, Hans Mallmin, Andreas Kindmark, Östen Ljunggren. (2009) Heterozygosity for a coding SNP in COL1A2 confers a lower BMD and an increased stroke risk. Biochemical and Biophysical Research Communications 384:4, 501-505
    CrossRef

  27. 27

    L. B. Husted, T. Harsløf, N. Gonzalez-Bofill, A. Schmitz, M. Carstens, L. Stenkjær, B. L. Langdahl. (2009) Haplotypes of Promoter and Intron 1 Polymorphisms in the COLIA1 Gene Are Associated with Increased Risk of Osteoporosis. Calcified Tissue International 84:2, 85-96
    CrossRef

  28. 28

    Tomohiko URANO, Masataka SHIRAKI, Takahiko USUI, Noriko SASAKI, Yasuyoshi OUCHI, Satoshi INOUE. (2009) A1330V Variant of the Low-density Lipoprotein Receptorrelated Protein 5 (LRP5) Gene Decreases Wnt Signaling and Affects the Total Body Bone Mineral Density in Japanese Women. Endocrine Journal 56:4, 625-631
    CrossRef

  29. 29

    Tom M. Palmer, John R. Thompson, Martin D. Tobin. (2008) Meta-analysis of Mendelian randomization studies incorporating all three genotypes. Statistics in Medicine 27:30, 6570-6582
    CrossRef

  30. 30

    Serge Ferrari. (2008) Human genetics of osteoporosis. Best Practice & Research Clinical Endocrinology & Metabolism 22:5, 723-735
    CrossRef

  31. 31

    Gregory J. Tranah, Brent C. Taylor, Li-Yung Lui, Joseph M. Zmuda, Jane A. Cauley, Kristine E. Ensrud, Teresa A. Hillier, Marc C. Hochberg, Jia Li, Brian K. Rhees, Henry A. Erlich, Mark D. Sternlicht, Gary Peltz, Steven R. Cummings, . (2008) Genetic Variation in Candidate Osteoporosis Genes, Bone Mineral Density, and Fracture Risk: The Study of Osteoporotic Fractures. Calcified Tissue International 83:3, 155-166
    CrossRef

  32. 32

    Ozlem Guzeloglu-Kayisli, Zafer Cetin, Ibrahim Keser, Zeynep Ozturk, Tiraje Tuncer, Duran Canatan, Guven Luleci. (2008) Relationship between SP1 polymorphism and osteoporosis in β-thalassemia major patients. Pediatrics International 50:4, 474-476
    CrossRef

  33. 33

    Leonid Kalichman, David J. Hunter. (2008) The genetics of intervertebral disc degeneration.Associated genes. Joint Bone Spine 75:4, 388-396
    CrossRef

  34. 34

    Min-Jeong Shin, Alka M. Kanaya, Ronald M. Krauss. (2008) Polymorphisms in the peroxisome proliferator activated receptor α gene are associated with levels of apolipoprotein CIII and triglyceride in African-Americans but not Caucasians. Atherosclerosis 198:2, 313-319
    CrossRef

  35. 35

    Albert Parés, Núria Guañabens. (2008) Osteoporosis in Primary Biliary Cirrhosis: Pathogenesis and Treatment. Clinics in Liver Disease 12:2, 407-424
    CrossRef

  36. 36

    Lei-Sheng Jiang, Zi-Ming Zhang, Sheng-Dan Jiang, Wei-Hua Chen, Li-Yang Dai. (2008) Differential Bone Metabolism Between Postmenopausal Women With Osteoarthritis and Osteoporosis. Journal of Bone and Mineral Research 23:4, 475-483
    CrossRef

  37. 37

    Pooneh Salari, Bagher Larijani, Mohammad Abdollahi. (2008) Association of hyperhomocysteinemia with osteoporosis: a systematic review. Therapy 5:2, 215-222
    CrossRef

  38. 38

    Mehmet Simsek, Zafer Cetin, Turker Bilgen, Omur Taskin, Guven Luleci, Ibrahim Keser. (2007) Effects of hormone replacement therapy on bone mineral density in Turkish patients with or without COL1A1 Sp1 binding site polymorphism. Journal of Obstetrics and Gynaecology Research 0:0, 071101174848006-???
    CrossRef

  39. 39

    Simone Funke, Éva Morava, Márta Czakó, Gabriella Vida, Tibor Ertl, György Kosztolányi. (2007) Koraszülöttek csontanyagcsere-betegsége és genetikai polimorfizmusok. Orvosi Hetilap 148:41, 1957-1965
    CrossRef

  40. 40

    S.-F. Lei, H. Jiang, F.-Y. Deng, H.-W. Deng. (2007) Searching for genes underlying susceptibility to osteoporotic fracture: current progress and future prospect. Osteoporosis International 18:9, 1157-1175
    CrossRef

  41. 41

    Nahid Yazdanpanah, Fernando Rivadeneira, Joyce B. J. Meurs, M. Carola Zillikens, P. Arp, Albert Hofman, Cornelia M. Duijn, Huibert A. P. Pols, André G. Uitterlinden. (2007) The -1997 G/T and Sp1 Polymorphisms in the Collagen Type I alpha1 (COLIA1) Gene in Relation to Changes in Femoral Neck Bone Mineral Density and the Risk of Fracture in the Elderly: The Rotterdam Study. Calcified Tissue International 81:1, 18-25
    CrossRef

  42. 42

    Struan FA Grant, Hakon Hakonarson. (2007) Recent development in pharmacogenomics: from candidate genes to genome-wide association studies. Expert Review of Molecular Diagnostics 7:4, 371-393
    CrossRef

  43. 43

    Tomohiko Urano, Masataka Shiraki, Yasuyoshi Ouchi, Satoshi Inoue. (2007) Association of a single nucleotide polymorphism in the steroid and xenobiotic receptor (SXR) gene (IVS1-579A/G) with bone mineral density. Geriatrics & Gerontology International 7:2, 104-109
    CrossRef

  44. 44

    Una L Fairbrother, László B Tankó, Andrew J Walley, Claus Christiansen, Philippe Froguel, Alexandra IF Blakemore. (2007) Leptin Receptor Genotype at Gln223Arg is Associated With Body Composition, BMD, and Vertebral Fracture in Postmenopausal Danish Women. Journal of Bone and Mineral Research 22:4, 544-550
    CrossRef

  45. 45

    Takahiko Usui, Tomohiko Urano, Masataka Shiraki, Yasuyoshi Ouchi, Satoshi Inoue. (2007) Association of a single nucleotide polymorphism in Wnt10bgene with bone mineral density. Geriatrics & Gerontology International 7:1, 48-53
    CrossRef

  46. 46

    Omar M.E. Albagha, Stuart H. Ralston. (2006) Genetics and Osteoporosis. Rheumatic Disease Clinics of North America 32:4, 659-680
    CrossRef

  47. 47

    Yukio Shima, Koji Teruya, Hidehiko Ohta. (2006) Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese. Life Sciences 79:23, 2234-2237
    CrossRef

  48. 48

    SIMONE FUNKE, ??VA MORAVA, M??RTA CZAK??, GABRIELLA VIDA, TIBOR ERTL, GY??RGY KOSZTOL??NYI. (2006) Influence of Genetic Polymorphisms on Bone Disease of Preterm Infants. Pediatric Research 60:5, 607-612
    CrossRef

  49. 49

    Miia Suuriniemi, Vuokko Kovanen, Anitta Mahonen, Markku Alén, Qingju Wang, Arja Lyytikäinen, Sulin Cheng. (2006) COL1A1 Sp1 polymorphism associates with bone density in early puberty. Bone 39:3, 591-597
    CrossRef

  50. 50

    Fernando Rivadeneira, Joyce BJ van Meurs, Jojanneke Kant, M Carola Zillikens, Lisette Stolk, Thomas J Beck, Pascal Arp, Stephanie CE Schuit, Albert Hofman, Jeanine J Houwing-Duistermaat, Cornelia M van Duijn, Johannes PTM van Leeuwen, Huibert AP Pols, André G Uitterlinden. (2006) Estrogen Receptor β (ESR2) Polymorphisms in Interaction With Estrogen Receptor α (ESR1) and Insulin-Like Growth Factor I (IGF1) Variants Influence the Risk of Fracture in Postmenopausal Women. Journal of Bone and Mineral Research 21:9, 1443-1456
    CrossRef

  51. 51

    Danny Chan, Youqiang Song, Pak Sham, Kenneth M. C. Cheung. (2006) Genetics of disc degeneration. European Spine Journal 15:S3, 317-325
    CrossRef

  52. 52

    Marco Medici, Joyce BJ van Meurs, Fernando Rivadeneira, HongYan Zhao, Pascal P Arp, Albert Hofman, Huibert AP Pols, André G Uitterlinden. (2006) BMP-2 Gene Polymorphisms and Osteoporosis: The Rotterdam Study. Journal of Bone and Mineral Research 21:6, 845-854
    CrossRef

  53. 53

    S. Viguet-Carrin, P. Garnero, P. D. Delmas. (2006) The role of collagen in bone strength. Osteoporosis International 17:3, 319-336
    CrossRef

  54. 54

    Barbara Obermayer-Pietsch. (2006) Genetics of Osteoporosis. Wiener Medizinische Wochenschrift 156:5-6, 162-167
    CrossRef

  55. 55

    Joyce BJ van Meurs, Fernando Rivadeneira, Mila Jhamai, Wendy Hugens, Albert Hofman, Johannes PTM van Leeuwen, Huibert AP Pols, André G Uitterlinden. (2006) Common Genetic Variation of the Low-Density Lipoprotein Receptor-Related Protein 5 and 6 Genes Determines Fracture Risk in Elderly White Men. Journal of Bone and Mineral Research 21:1, 141-150
    CrossRef

  56. 56

    Yangsoo Jang, Jong Ho Lee, Oh Yoen Kim, Soo Jeong Koh, Jey Sook Chae, Jin Hee Woo, Hongkeun Cho, Jong Eun Lee, Jose M. Ordovas. (2006) The SNP276G>T polymorphism in the adiponectin (ACDC) gene is more strongly associated with insulin resistance and cardiovascular disease risk than SNP45T>G in nonobese/nondiabetic Korean men independent of abdominal adiposity and circulating plasma adiponectin. Metabolism 55:1, 59-66
    CrossRef

  57. 57

    Stuart H. Ralston, André G. Uitterlinden, Maria Luisa Brandi, Susana Balcells, Bente L. Langdahl, Paul Lips, Roman Lorenc, Barbara Obermayer-Pietsch, Serena Scollen, Mariona Bustamante, Lise Bjerre Husted, Alisoun H. Carey, Adolfo Diez-Perez, Alison M. Dunning, Alberto Falchetti, Elzbieta Karczmarewicz, Marcin Kruk, Johannes P. T. M. van Leeuwen, Joyce B. J. van Meurs, Jon Mangion, Fiona E. A. McGuigan, Leonardo Mellibovsky, Francesca del Monte, Huibert A. P. Pols, Jonathan Reeve, David M. Reid, Wilfried Renner, Fernando Rivadeneira, Natasja M. van Schoor, Rachael E. Sherlock, John P. A. Ioannidis, . (2006) Large-Scale Evidence for the Effect of the COLIA1 Sp1 Polymorphism on Osteoporosis Outcomes: The GENOMOS Study. PLoS Medicine 3:4, e90
    CrossRef

  58. 58

    Hong-yan Zhao, Jian-min Liu, Guang Ning, Yong-ju Zhao, Lian-zhen Zhang, Li-hao Sun, Man-yin Xu, A. G. Uitterlinden, Jia-lun Chen. (2005) The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women. Osteoporosis International 16:12, 1519-1524
    CrossRef

  59. 59

    Yue Fang, Joyce B.J. van Meurs, Arnold d'Alesio, Mila Jhamai, Hongyan Zhao, Fernando Rivadeneira, Albert Hofman, Johannes P.T. van Leeuwen, Frédéric Jehan, Huibert A.P. Pols, André G. Uitterlinden. (2005) Promoter and 3′-Untranslated-Region Haplotypes in the Vitamin D Receptor Gene Predispose to Osteoporotic Fracture: The Rotterdam Study. The American Journal of Human Genetics 77:5, 807-823
    CrossRef

  60. 60

    Rebecca Lamb, Wendy Thomson, Emma Ogilvie, , Rachelle Donn. (2005) Wnt-1-inducible signaling pathway protein 3 and susceptibility to juvenile idiopathic arthritis. Arthritis & Rheumatism 52:11, 3548-3553
    CrossRef

  61. 61

    A.P. Bergink, A.G. Uitterlinden, J.P.T.M. Van Leeuwen, A. Hofman, J.A.N. Verhaar, H.A.P. Pols. (2005) Bone mineral density and vertebral fracture history are associated with incident and progressive radiographic knee osteoarthritis in elderly men and women: The Rotterdam Study. Bone 37:4, 446-456
    CrossRef

  62. 62

    Wesley G. Beamer, Kathryn L. Shultz, Leah Rae Donahue, Gary A. Churchill, Saunak Sen, Jon R. Wergedal, David J. Baylink, Clifford J. Rosen. (2005) Quantitative Trait Loci for Femoral and Lumbar Vertebral Bone Mineral Density in C57BL/6J and C3H/HeJ Inbred Strains of Mice. Journal of Bone and Mineral Research 20:9, 1700-1712
    CrossRef

  63. 63

    Stuart H Ralston. (2005) Genetic determinants of osteoporosis. Current Opinion in Rheumatology 17:4, 475-479
    CrossRef

  64. 64

    Yoshiji Yamada, Fujiko Ando, Hiroshi Shimokata. (2005) Association of polymorphisms in CYP17A1, MTP, and VLDLR with bone mineral density in community-dwelling Japanese women and men. Genomics 86:1, 76-85
    CrossRef

  65. 65

    Heini Hartikka, Outi Mäkitie, Minna Männikkö, Andrea S Doria, Alan Daneman, William G Cole, Leena Ala-Kokko, Etienne B Sochett. (2005) Heterozygous Mutations in the LDL Receptor-Related Protein 5 (LRP5) Gene Are Associated With Primary Osteoporosis in Children. Journal of Bone and Mineral Research 20:5, 783-789
    CrossRef

  66. 66

    David Gurwitz. (2005) Workshop Abstracts. Personalized Medicine 2:2, 145-185
    CrossRef

  67. 67

    K. Lian, J. M. Zmuda, M. C. Nevitt, L. Lui, M. C. Hochberg, D. Greene, J. Li, J. Wang, N. E. Lane. (2005) Type I collagen α1 Sp1 transcription factor binding site polymorphism is associated with reduced risk of hip osteoarthritis defined by severe joint space narrowing in elderly women. Arthritis & Rheumatism 52:5, 1431-1436
    CrossRef

  68. 68

    J. Bollerslev, S.G. Wilson, I.M. Dick, F.M.A. Islam, T. Ueland, L. Palmer, A. Devine, R.L. Prince. (2005) LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women. Bone 36:4, 599-606
    CrossRef

  69. 69

    Yuan-Yuan Zhang, Shu-Feng Lei, Xiao-Yang Mo, Yan-Bo Wang, Miao-Xin Li, Hong-Wen Deng. (2005) The −1997 G/T Polymorphism in the COLIA1 Upstream Regulatory Region is Associated with Hip Bone Mineral Density (BMD) in Chinese Nuclear Families. Calcified Tissue International 76:2, 107-112
    CrossRef

  70. 70

    M. Weichetova, J. J. Stepan, T. Haas, D. Michalska. (2005) The Risk of Colles’ Fracture is Associated with the Collagen I Alpha1 Sp1 Polymorphism and Ultrasound Transmission Velocity in the Calcaneus Only in Heavier Postmenopausal Women. Calcified Tissue International 76:2, 98-106
    CrossRef

  71. 71

    Yoshiji Yamada, Fujiko Ando, Naoakira Niino, Hiroshi Shimokata. (2005) Association of polymorphisms of the androgen receptor and klotho genes with bone mineral density in Japanese women. Journal of Molecular Medicine 83:1, 50-57
    CrossRef

  72. 72

    Andre G. Uitterlinden, Pascal P. Arp, Bryan W. Paeper, Patrick Charmley, Sean Proll, Fernando Rivadeneira, Yue Fang, Joyce B.J. van Meurs, Theresa B. Britschgi, John A. Latham, Randall C. Schatzman, Huibert A.P. Pols, Mary E. Brunkow. (2004) Polymorphisms in the Sclerosteosis/van Buchem Disease Gene (SOST) Region Are Associated with Bone-Mineral Density in Elderly Whites. The American Journal of Human Genetics 75:6, 1032-1045
    CrossRef

  73. 73

    M. Cohen-Solal, M.-C. de Vernejoul. (2004) Génetique de l'ostéoporose. La Revue de Médecine Interne 25, S526-S530
    CrossRef

  74. 74

    Eleftherios P Paschalis, Elizabeth Shane, George Lyritis, Grigoris Skarantavos, Richard Mendelsohn, Adele L Boskey. (2004) Bone Fragility and Collagen Cross-Links. Journal of Bone and Mineral Research 19:12, 2000-2004
    CrossRef

  75. 75

    Pedro Mezquita-Raya, Manuel Muoz-Torres, Guillermo Alonso, Juan Dios Luna, Jose Manuel Quesada, Gabriel Dorado, Fernando Luque-Recio, Maria Estrella Ruiz-Requena, Francisca Lopez-Rodriguez, Fernando Escobar-Jimnez. (2004) Susceptibility for Postmenopausal Osteoporosis: Interaction Between Genetic, Hormonal and Lifestyle Factors. Calcified Tissue International 75:5, 373-379
    CrossRef

  76. 76

    Mariette WCJ Schoofs, Marjolein van der Klift, Albert Hofman, Cornelia M van Duijn, Bruno HCh Stricker, Huibert AP Pols, André G Uitterlinden. (2004) ApoE Gene Polymorphisms, BMD, and Fracture Risk in Elderly Men and Women: The Rotterdam Study. Journal of Bone and Mineral Research 19:9, 1490-1496
    CrossRef

  77. 77

    Masayo Fujita, Tomohiko Urano, Masataka Shiraki, Mikio Momoeda, Osamu Tsutsumi, Takayuki Hosoi, Hajime Orimo, Yasuyoshi Ouchi, Satoshi Inoue. (2004) Association of a single nucleotide polymorphism in the secreted frizzled-related protein 4 (sFRP4) gene with bone mineral density. Geriatrics and Gerontology International 4:3, 175-180
    CrossRef

  78. 78

    Fernando Rivadeneira, Jeanine J Houwing-Duistermaat, Thomas J Beck, Joop AMJL Janssen, Albert Hofman, Huibert AP Pols, Cornelia M van Duijn, Andre' G Uitterlinden. (2004) The Influence of an Insulin-Like Growth Factor I Gene Promoter Polymorphism on Hip Bone Geometry and the Risk of Nonvertebral Fracture in the Elderly: The Rotterdam Study. Journal of Bone and Mineral Research 19:8, 1280-1290
    CrossRef

  79. 79

    Daniel L Koller, Munro Peacock, Dongbing Lai, Tatiana Foroud, Michael J Econs. (2004) False Positive Rates in Association Studies as a Function of Degree of Stratification. Journal of Bone and Mineral Research 19:8, 1291-1295
    CrossRef

  80. 80

    B Ongphiphadhanakul, S Chanprasertyothin, L Chailurkit, S Chansirikarn, G Puavilai, R Rajatanavin. (2004) Differential associations of residual estradiol levels with bone mineral density and serum lipids in postmenopausal women with osteoporosis. Maturitas 48:3, 193-196
    CrossRef

  81. 81

    Tanya Vaughan, David M Reid, Nigel A Morrison, Stuart H Ralston. (2004) RUNX2 alleles associated with BMD in Scottish women; interaction of RUNX2 alleles with menopausal status and body mass index. Bone 34:6, 1029-1036
    CrossRef

  82. 82

    Serge L Ferrari, David Karasik, Jun Liu, Samev Karamohamed, Alan G Herbert, L Adrienne Cupples, Douglas P Kiel. (2004) Interactions of Interleukin-6 Promoter Polymorphisms With Dietary and Lifestyle Factors and Their Association With Bone Mass in Men and Women From the Framingham Osteoporosis Study. Journal of Bone and Mineral Research 19:4, 552-559
    CrossRef

  83. 83

    Karine Robert, Nicole Maurin, Catherine Vayssettes, Nathalie Siauve, Nathalie Janel. (2004) Cystathionine ? synthase deficiency affects mouse endochondral ossification. The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology
    CrossRef

  84. 84

    Elena Ruza, Elena Sotillo, Luis Sierrases??maga, Cristina Azcona, Ana Pati??o-Garc??a. (2003) Analysis of Polymorphisms of the Vitamin D Receptor, Estrogen Receptor, and Collagen I??1 Genes and Their Relationship With Height in Children With Bone Cancer. Journal of Pediatric Hematology/Oncology 25:10, 780-786
    CrossRef

  85. 85

    I.M Dick, A Devine, S Li, S.S Dhaliwal, R.L Prince. (2003) The T869C TGF β polymorphism is associated with fracture, bone mineral density, and calcaneal quantitative ultrasound in elderly women. Bone 33:3, 335-341
    CrossRef

  86. 86

    Ryota Ishida, Yoichi Ezura, Mitsuru Emi, Mitsuko Kajita, Hideo Yoshida, Takao Suzuki, Takayuki Hosoi, Satoshi Inoue, Masataka Shiraki, Hiromoto Ito, Hajime Orimo. (2003) Association of a promoter haplotype (−1542G/−525C) in the tumor necrosis factor receptor associated factor-interacting protein gene with low bone mineral density in Japanese women. Bone 33:2, 237-241
    CrossRef

  87. 87

    Daniel Alvarez-Hernandez, Manuel Naves, J. Bernardino Diaz-Lopez, Carlos Gomez, Inigo Santamaria, Jorge B. Cannata-Andia. (2003) Influence of polymorphisms in VDR and COLIA1 genes on the risk of osteoporotic fractures in aged men. Kidney International 63:s85, 14-18
    CrossRef

  88. 88

    V Mann, S.H Ralston. (2003) Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture. Bone 32:6, 711-717
    CrossRef

  89. 89

    J. Pfeilschifter. (2003) Genetik der Osteoporose: Der COLIA1-Sp1-Polymorphismus/Genetics of Osteoporosis: The COLIA1-Sp1-Polymorphism. LaboratoriumsMedizin 27:3-4, 92-99
    CrossRef

  90. 90

    BO Abrahamsen, Jonna Skov Madsen, Charlotte Landbo Tofteng, Lis Stilgren, Else Marie Bladbjerg, Søren Risom Kristensen, Kim Brixen, Leif Mosekilde. (2003) A Common Methylenetetrahydrofolate Reductase (C677T) Polymorphism Is Associated With Low Bone Mineral Density and Increased Fracture Incidence After Menopause: Longitudinal Data From the Danish Osteoporosis Prevention Study. Journal of Bone and Mineral Research 18:4, 723-729
    CrossRef

  91. 91

    Francis Vasseur, Frédéric Leprêtre, Corinne Lacquemant, Philippe Froguel. (2003) The genetics of adiponectin. Current Diabetes Reports 3:2, 151-158
    CrossRef

  92. 92

    Ryota Ishida, Mitsuru Emi, Yoichi Ezura, Hironori Iwasaki, Hideyo Yoshida, Takao Suzuki, Takayuki Hosoi, Satoshi Inoue, Masataka Shiraki, Hiromoto Ito, Hajime Orimo. (2003) Association of a Haplotype (196Phe/532Ser) in the Interleukin-1-Receptor-Associated Kinase (IRAK1) Gene With Low Radial Bone Mineral Density in Two Independent Populations. Journal of Bone and Mineral Research 18:3, 419-423
    CrossRef

  93. 93

    Boonsong Ongphiphadhanakul. (2003) Genetic Polymorphisms of Estrogen Receptor-??. American Journal of PharmacoGenomics 3:1, 5-9
    CrossRef

  94. 94

    K.M. Jordan, C. Cooper. (2002) Epidemiology of osteoporosis. Best Practice & Research Clinical Rheumatology 16:5, 795-806
    CrossRef

  95. 95

    I.M Dick, A Devine, A Marangou, S.S Dhaliwal, S Laws, R.N Martins, R.L Prince. (2002) Apolipoprotein E4 is associated with reduced calcaneal quantitative ultrasound measurements and bone mineral density in elderly women. Bone 31:4, 497-502
    CrossRef

  96. 96

    Ken-Ichi Kawano, Naoshi Ogata, Mathias Chiano, Helen Molloy, Patrick Kleyn, Tim D. Spector, Motoyuki Uchida, Takayuki Hosoi, Takao Suzuki, Hajime Orimo, Satoshi Inoue, Yoichi Nabeshima, Kozo Nakamura, Makoto Kuro-O, Hiroshi Kawaguchi. (2002) Klotho Gene Polymorphisms Associated With Bone Density of Aged Postmenopausal Women. Journal of Bone and Mineral Research 17:10, 1744-1751
    CrossRef

  97. 97

    Fiona E.A. McGuigan, Stuart H. Ralston. (2002) Single nucleotide polymorphism detection:allelic discrimination using TaqMan. Psychiatric Genetics 12:3, 133-136
    CrossRef

  98. 98

    Sumito Ogawa, Mitsuru Emi, Masataka Shiraki, Takayuki Hosoi, Hajime Orimo, Yasuyoshi Ouchi, Satoshi Inoue. (2002) Association of amino acid variation (Trp64Arg) in the beta3-adrenergic receptor gene with bone mineral density. Geriatrics and Gerontology International 2:3, 138-142
    CrossRef

  99. 99

    Tanya Vaughan, Julie A. Pasco, Mark A. Kotowicz, Geoff C. Nicholson, Nigel A. Morrison. (2002) Alleles of RUNX2/CBFA1 Gene Are Associated With Differences in Bone Mineral Density and Risk of Fracture. Journal of Bone and Mineral Research 17:8, 1527-1534
    CrossRef

  100. 100

    P Garnero, O Borel, E Sornay-Rendu, F Duboeuf, R Jeffery, P Woo, P.D Delmas. (2002) Association between a functional interleukin-6 gene polymorphism and peak bone mineral density and postmenopausal bone loss in women: the ofely study. Bone 31:1, 43-50
    CrossRef

  101. 101

    D.B Burr. (2002) The contribution of the organic matrix to bone’s material properties. Bone 31:1, 8-11
    CrossRef

  102. 102

    Fiona E. A. Mcguigan, Liam Murray, Alison Gallagher, George Davey-Smith, Charlotte E. Neville, Rob Van't Hof, Colin Boreham, Stuart H. Ralston. (2002) Genetic and Environmental Determinants of Peak Bone Mass in Young Men and Women. Journal of Bone and Mineral Research 17:7, 1273-1279
    CrossRef

  103. 103

    N Ogata, Y Matsumura, M Shiraki, K Kawano, Y Koshizuka, T Hosoi, K Nakamura, M Kuro-o, H Kawaguchi. (2002) Association of klotho gene polymorphism with bone density and spondylosis of the lumbar spine in postmenopausal women. Bone 31:1, 37-42
    CrossRef

  104. 104

    Yoshiji Yamada, Fujiko Ando, Naoakira Niino, Hiroshi Shimokata. (2002) Association of a Polymorphism of the CC Chemokine Receptor-2 Gene with Bone Mineral Density. Genomics 80:1, 8-12
    CrossRef

  105. 105

    Lucio Montanaro, Carla Renata Arciola. (2002) Allele Frequency of the G→T Mutation of the Col1A1 Gene Analyzed by an ARMS-PCR in Osteoporotic Subjects with Femoral Neck Fractures. Clinical Chemistry and Laboratory Medicine 40:6, 550-553
    CrossRef

  106. 106

    Barbara Arko, Janez Preželj, Radovan Komel, Andreja Kocijančič, Janja Marc. (2002) No major effect of estrogen receptor beta gene RsaI polymorphism on bone mineral density and response to alendronate therapy in postmenopausal osteoporosis. The Journal of Steroid Biochemistry and Molecular Biology 81:2, 147-152
    CrossRef

  107. 107

    Ego Seeman. (2002) Pathogenesis of bone fragility in women and men. The Lancet 359:9320, 1841-1850
    CrossRef

  108. 108

    Richard Eastell, Helen Lambert. (2002) Plenary Lecture: Strategies for skeletal health in the elderly. Proceedings of the Nutrition Society 61:02, 173-180
    CrossRef

  109. 109

    P. Volders, J. Van Hove, R.J.U. Lories, Ph. Vandekerckhove, G. Matthijs, R. De Vos, M.T. Vanier, M.F. Vincent, R. Westhovens, F.P. Luyten. (2002) Niemann-Pick disease type B: An unusual clinical presentation with multiple vertebral fractures. American Journal of Medical Genetics 109:1, 42-51
    CrossRef

  110. 110

    Lucio Montanaro, Carla Renata Arciola. (2002) Detection of the G→T Polymorphism at the Sp1 Binding Site of the Collagen Type I α 1 Gene by a Novel Arms-PCR Method. Genetic Testing 6:1, 53-57
    CrossRef

  111. 111

    Natalia Garcia-Giralt, Xavier Nogués, Anna Enjuanes, Jordi Puig, Leonardo Mellibovsky, Anne Bay-Jensen, Ramon Carreras, Susana Balcells, Adolfo Díez-Pérez, Daniel Grinberg. (2002) Two New Single-Nucleotide Polymorphisms in the COL1A1 Upstream Regulatory Region and Their Relationship to Bone Mineral Density. Journal of Bone and Mineral Research 17:3, 384-393
    CrossRef

  112. 112

    Noriko Kobayashi, Takafumi Fujino, Toru Shirogane, Itsuko Furuta, Yoko Kobamatsu, Minoru Yaegashi, Noriaki Sakuragi, Seiichiro Fujimoto. (2002) Estrogen receptor α polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen. Maturitas 41:3, 193-201
    CrossRef

  113. 113

    S Mirandola. (2002) Rapid and efficient genotype analysis of the COL1A1 Sp1 binding site dimorphism, a genetic marker for bone mineral density. Molecular and Cellular Probes 16:1, 73-75
    CrossRef

  114. 114

    M Bernad, M.E Martinez, M Escalona, M.L González, C González, M.V Garcés, M.T Del Campo, E Martı́n Mola, R Maderò, L Carreñò. (2002) Polymorphism in the type I collagen (COLIA1) gene and risk of fractures in postmenopausal women. Bone 30:1, 223-228
    CrossRef

  115. 115

    Hong-Wen Deng, Michael C. Mahaney, Jeff T. Williams, Jing Li, Theresa Conway, K. Michael Davies, Jin-Long Li, Hongyi Deng, Robert R. Recker. (2002) Relevance of the genes for bone mass variation to susceptibility to osteoporotic fractures and its implications to gene search for complex human diseases. Genetic Epidemiology 22:1, 12-25
    CrossRef

  116. 116

    Yoshiji Yamada. (2001) Association of polymorphisms of the transforming growth factor-??1 gene with genetic susceptibility to osteoporosis. Pharmacogenetics 11:9, 765-771
    CrossRef

  117. 117

    Sophie Roux. (2001) The genetics of osteoporosis. Joint Bone Spine 68:6, 482-486
    CrossRef

  118. 118

    Francesco Massart, Jean Yves Reginster, Maria Luisa Brandi. (2001) Genetics of menopause-associated diseases. Maturitas 40:2, 103-116
    CrossRef

  119. 119

    Helen M. Macdonald, Fiona A. McGuigan, Susan A. New, Marion K. Campbell, Michael H. N. Golden, Stuart H. Ralston, David M. Reid. (2001) COL1A1 Sp1 Polymorphism Predicts Perimenopausal and Early Postmenopausal Spinal Bone Loss. Journal of Bone and Mineral Research 16:9, 1634-1641
    CrossRef

  120. 120

    Zoe Efstathiadou, Agathocles Tsatsoulis, John P. A. Ioannidis. (2001) Association of Collagen Iα 1 Sp1 Polymorphism with the Risk of Prevalent Fractures: A Meta-Analysis. Journal of Bone and Mineral Research 16:9, 1586-1592
    CrossRef

  121. 121

    Pieter Huijbers, Dick L Knook. (2001) Biological ageing research in the Netherlands. Experimental Gerontology 36:8, 1221-1249
    CrossRef

  122. 122

    Annukka Vinkanharju, Tarja Melkko, Juha Risteli, Leila Risteli. (2001) New PCR-Based Method for the Sp1 Site Polymorphism in the COL1A1 Gene. Clinical Chemistry and Laboratory Medicine 39:7, 624-626
    CrossRef

  123. 123

    Elaine M. Dennison, Nigel K. Arden, Richard W. Keen, Holly Syddall, Ian N. M. Day, Timothy D. Spector, Cyrus Cooper. (2001) Birthweight, vitamin D receptor genotype and the programming of osteoporosis. Paediatric and Perinatal Epidemiology 15:3, 211-219
    CrossRef

  124. 124

    Wesley G. Beamer, Kathryn L. Shultz, Leah Rae Donahue, Gary A. Churchill, Saunak Sen, Jon R. Wergedal, David J. Baylink, Clifford J. Rosen. (2001) Quantitative Trait Loci for Femoral and Lumbar Vertebral Bone Mineral Density in C57BL/6J and C3H/HeJ Inbred Strains of Mice. Journal of Bone and Mineral Research 16:7, 1195-1206
    CrossRef

  125. 125

    R.L. Prince. (2001) How to diagnose the presence of osteoporosis and assess the risk of fracture. Best Practice & Research Clinical Rheumatology 15:3, 345-358
    CrossRef

  126. 126

    Charles N. Bernstein. (2001) All Patients with Inflammatory Bowel Disease Should Have Bone Density Assessment. Inflammatory Bowel Diseases 7:2, 168-169
    CrossRef

  127. 127

    Matthew A. Brown, Margaret A. Haughton, Struan F. A. Grant, Anthony S. Gunnell, N. Kathryn Henderson, John A. Eisman. (2001) Genetic Control of Bone Density and Turnover: Role of the Collagen 1α1, Estrogen Receptor, and Vitamin D Receptor Genes. Journal of Bone and Mineral Research 16:4, 758-764
    CrossRef

  128. 128

    Val Mann, Emma E. Hobson, Baohua Li, Tracy L. Stewart, Struan F.A. Grant, Simon P. Robins, Richard M. Aspden, Stuart H. Ralston. (2001) A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. Journal of Clinical Investigation 107:7, 899-907
    CrossRef

  129. 129

    Karen Walker-Bone, Elaine Dennison, Cyrus Cooper. (2001) Epidemiology of Osteoporosis. Rheumatic Disease Clinics of North America 27:1, 1-18
    CrossRef

  130. 130

    André G. Uitterlinden, Angelique E. A. M. Weel, Huib Burger, Yue Fang, Cornelia M. Van Duijn, Albert Hofman, Johannes P. T. M Van Leeuwen, Huibert A. P. Pols. (2001) Interaction Between the Vitamin D Receptor Gene and Collagen Type Iα1 Gene in Susceptibility for Fracture. Journal of Bone and Mineral Research 16:2, 379-385
    CrossRef

  131. 131

    S. L. Ferrari. (2001) Genomics and Osteoporosis: What Are the Implications?. International Bone and Mineral Society Knowledge Environment 1:1, 20040121-0
    CrossRef

  132. 132

    Tianhua Niu, Xiping Xu. (2001) Candidate Genes for Osteoporosis. American Journal of PharmacoGenomics 1:1, 11-19
    CrossRef

  133. 133

    S. L. Ferrari, P. Garnero, S. Emond, H. Montgomery, S. E. Humphries, S. L. Greenspan. (2001) A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women. Arthritis & Rheumatism 44:1, 196-201
    CrossRef

  134. 134

    Emma E. Hobson, Stuart H. Ralston. (2001) Role of genetic factors in the pathophysiology and management of osteoporosis. Clinical Endocrinology 54:1, 1-9
    CrossRef

  135. 135

    Rivka Dresner Pollak, Eliezer Rachmilewitz, Anat Blumenfeld, Maria Idelson, Ada W. Goldfarb. (2000) Bone mineral metabolism in adults with beta-thalassaemia major and intermedia. British Journal of Haematology 111:3, 902-907
    CrossRef

  136. 136

    Rivka Dresner Pollak, Eliezer Rachmilewitz, Anat Blumenfeld, Maria Idelson, Ada W. Goldfarb. (2000) Bone mineral metabolism in adults with β-thalassaemia major and intermedia. British Journal of Haematology 111:3, 902-907
    CrossRef

  137. 137

    Timo Salmén, Anna-Mari Heikkinen, Anitta Mahonen, Heikki Kröger, Marja Komulainen, Seppo Saarikoski, Risto Honkanen, Pekka H. Mäenpää. (2000) The Protective Effect of Hormone-Replacement Therapy on Fracture Risk Is Modulated by Estrogen Receptor α Genotype in Early Postmenopausal Women. Journal of Bone and Mineral Research 15:12, 2479-2486
    CrossRef

  138. 138

    Silverio Perrotta, Maria Domenica Cappellini, Francesco Bertoldo, Veronica Servedio, Giovanni Iolascon, Leonardo D'agruma, Paolo Gasparini, Maria Carmen Siciliani, Achille Iolascon. (2000) Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background. British Journal of Haematology 111:2, 461-466
    CrossRef

  139. 139

    Silverio Perrotta, Maria Domenica Cappellini, Francesco Bertoldo, Veronica Servedio, Giovanni Iolascon, Leonardo D'agruma, Paolo Gasparini, Maria Carmen Siciliani, Achille Iolascon. (2000) Osteoporosis in β-thalassaemia major patients: analysis of the genetic background. British Journal of Haematology 111:2, 461-466
    CrossRef

  140. 140

    L. B. Henderson, J. S. Adams, D. R. Goldstein, G. D. Braunstein, J. I. Rotter, M. T. Scheuner. (2000) A familial risk profile for osteoporosis. Genetics in Medicine 2:4, 222-225
    CrossRef

  141. 141

    L. D. Spotila, H. Rodriguez, M. Koch, K. Adams, J. Caminis, H. S. Tenenhouse, A. Tenenhouse. (2000) Association of a Polymorphism in the TNFR2 Gene with Low Bone Mineral Density. Journal of Bone and Mineral Research 15:7, 1376-1383
    CrossRef

  142. 142

    Clifford J. Rosen. (2000) Pathogenesis of osteoporosis. Best Practice & Research Clinical Endocrinology & Metabolism 14:2, 181-193
    CrossRef

  143. 143

    Yves Giguère, Sylvie Dodin, Claudine Blanchet, Kenneth Morgan, François Rousseau. (2000) The Association Between Heel Ultrasound and Hormone Replacement Therapy Is Modulated by a Two-Locus Vitamin D and Estrogen Receptor Genotype. Journal of Bone and Mineral Research 15:6, 1076-1084
    CrossRef

  144. 144

    Bente L. Langdahl, Elsebet Løkke, Mette Carstens, Lise Lotte Stenkjaer, Erik Fink Eriksen. (2000) Osteoporotic Fractures Are Associated with an 86-Base Pair Repeat Polymorphism in the Interleukin-1-Receptor Antagonist Gene But Not with Polymorphisms in the Interleukin-1β Gene. Journal of Bone and Mineral Research 15:3, 402-414
    CrossRef

  145. 145

    M Weichetová, J.J Štěpán, D Michalská, T Haas, H.A.P Pols, A.G Uitterlinden. (2000) COLIA1 polymorphism contributes to bone mineral density to assess prevalent wrist fractures. Bone 26:3, 287-290
    CrossRef

  146. 146

    M Inoue, H Tanaka, T Moriwake, M Oka, C Sekiguchi, Y Seino. (2000) Altered biochemical markers of bone turnover in humans during 120 days of bed rest. Bone 26:3, 281-286
    CrossRef

  147. 147

    Tomohiko Urano, Takayuki Hosoi, Masataka Shiraki, Hideo Toyoshima, Yasuyoshi Ouchi, Satoshi Inoue. (2000) Possible Involvement of the p57Kip2 Gene in Bone Metabolism. Biochemical and Biophysical Research Communications 269:2, 422-426
    CrossRef

  148. 148

    Yves Giguère, François Rousseau. (2000) The genetics of osteoporosis: ‘complexities and difficulties’. Clinical Genetics 57:3, 161-169
    CrossRef

  149. 149

    Laurence A. Rubin, Millan S. Patel, David E. C. Cole. (2000) Genetic determinants of bone mass acquisition and risk for osteoporosis. Drug Development Research 49:3, 216-226
    CrossRef

  150. 150

    Yoshiji Yamada, Atsushi Harada, Takayuki Hosoi, Akimitsu Miyauchi, Kyoji Ikeda, Hiroaki Ohta, Masataka Shiraki. (2000) Association of Transforming Growth Factor β1 Genotype with Therapeutic Response to Active Vitamin D for Postmenopausal Osteoporosis. Journal of Bone and Mineral Research 15:3, 415-420
    CrossRef

  151. 151

    Randi L. Wolf, Katie L. Stone, Jane A. Cauley. (2000) Update on the epidemiology of osteoporosis. Current Rheumatology Reports 2:1, 74-86
    CrossRef

  152. 152

    Y. Z. Bagger, C. Hassager, A.-M. Heegaard, C. Christiansen. (2000) Vitamin D receptor and estrogen receptor gene polymorphisms in postmenopausal Danish women: no relation to bone markers or serum lipoproteins. Climacteric 3:2, 84-91
    CrossRef

  153. 153

    Jenny Heathcote. (1999) Osteoporosis in chronic liver disease. Current Gastroenterology Reports 1:6, 455-458
    CrossRef

  154. 154

    Darwin J. Prockop. (1999) Genetic Trail of Osteoporosis: Candidate Genes Versus Genome Screens? Small Families Versus Large Families?. Journal of Bone and Mineral Research 14:12, 2000-2001
    CrossRef

  155. 155

    Sylvia T Singer, Elliott P Vichinsky. (1999) Bone disease in β-thalassaemia. The Lancet 354:9182, 881-882
    CrossRef

  156. 156

    Maryfran Sowers, Marcia Willing, Trudy Burns, Sachi Deschenes, Bruce Hollis, Mary Crutchfield, Mary Jannausch. (1999) Genetic Markers, Bone Mineral Density, and Serum Osteocalcin Levels. Journal of Bone and Mineral Research 14:8, 1411-1419
    CrossRef

  157. 157

    S.H Ralston. (1999) The genetics of osteoporosis. Bone 25:1, 85-86
    CrossRef

  158. 158

    Sumito Ogawa, Tomohiko Urano, Takayuki Hosoi, Mariko Miyao, Shinjiro Hoshino, Masayo Fujita, Masataka Shiraki, Hajime Orimo, Yasuyoshi Ouchi, Satoshi Inoue. (1999) Association of Bone Mineral Density with a Polymorphism of the Peroxisome Proliferator-Activated Receptor γ Gene: PPARγ Expression in Osteoblasts. Biochemical and Biophysical Research Communications 260:1, 122-126
    CrossRef

  159. 159

    Sheriar G. Hormuzdi, Thomas P. Strandjord, David K. Madtes, Paul Bornstein. (1999) Mice with a targeted intronic deletion in the Col1a1 gene respond to bleomycin-induced pulmonary fibrosis with increased expression of the mutant allele. Matrix Biology 18:3, 287-294
    CrossRef

  160. 160

    Bijoy Kundu, Sanjay K Khare, Geeta Singh. (1999) Role of polypeptides in the treatment and diagnosis of osteoporosis. Peptides 20:4, 523-537
    CrossRef

  161. 161

    A. L. Boskey, T. M. Wright, R. D. Blank. (1999) Collagen and Bone Strength. Journal of Bone and Mineral Research 14:3, 330-335
    CrossRef

  162. 162

    Robert D. Blank. (1999) Linkage, Association, and the Genetic Analysis of Bone Mineral Density and Related Phenotypes. Journal of Clinical Densitometry 2:1, 59-70
    CrossRef

  163. 163

    R. W. Keen, K. L. Woodford-Richens, S. F. A. Grant, S. H. Ralston, J. S. Lanchbury, T. D. Spector. (1999) Association of polymorphism at the type I collagen (COL1A1) locus with reduced bone mineral density, increased fracture risk, and increased collagen turnover. Arthritis & Rheumatism 42:2, 285-290
    CrossRef

  164. 164

    Takayuki Hosoi. (1999) Genetic analysis and clinical application in polygenic diseases. Osteoporosis.. Nippon Ika Daigaku Zasshi 66:5, 327-328
    CrossRef

  165. 165

    Joseph M. Zmuda, Jane A. Cauley, Robert E. Ferrell. (1999) Recent progress in understanding the genetic susceptibility to osteoporosis. Genetic Epidemiology 16:4, 356-367
    CrossRef

  166. 166

    Wonke. (1998) BONE DISEASE IN beta-THALASSAEMIA MAJOR. British Journal of Haematology 103:4, 897-901
    CrossRef

  167. 167

    Dennis Ledford, Andrea Apter, Anne Manon Brenner, Karen Rubin, Karen Prestwood, Marianne Frieri, Barbara Lukert. (1998) Osteoporosis in the corticosteroid-treated patient with asthma. Journal of Allergy and Clinical Immunology 102:3, 353-362
    CrossRef

  168. 168

    Beavan, Sian, Prentice, Ann, Dibba, Bakary, , Yan, Liya, Cooper, Cyrus, Ralston, Stuart H., . (1998) Polymorphism of the Collagen Type Iα1 Gene and Ethnic Differences in Hip-Fracture Rates. New England Journal of Medicine 339:5, 351-352
    Full Text

  169. 169

    Vicente Gilsanz. (1998) Phenotype and Genotype of Osteoporosis. Trends in Endocrinology & Metabolism 9:5, 184-190
    CrossRef

  170. 170

    Prockop, Darwin J., . (1998) The Genetic Trail of Osteoporosis. New England Journal of Medicine 338:15, 1061-1062
    Full Text